Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03897881
Brief Title: An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

First Submitted : March 29, 2019
First Submitted that Met QC Criteria : March 29, 2019
First Posted : April 1, 2019

Last Update Submitted that Met QC Criteria : May 28, 2021
Last Update Posted : June 2, 2021